Conference on lung development and fibrosis interactions
Official title: The 2024 conference on "Epithelial mesenchymal interactions in lung development and fibrosis"
Funded at Mayo Clinic Rochester · NIH-11000509 · Data updated 2026-11-12
This conference is all about how different types of lung cells work together, especially after serious injuries like those caused by COVID-19, and it aims to share new ideas to help improve lung healing and care for people with ongoing breathing problems.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project start | October 1, 2024 |
| Project end | September 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $5,000 |
| NIH project number | 1R13HL176063-01 |
| Project ID | NIH-11000509 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit include individuals recovering from severe lung injuries, such as those affected by COVID-19 or other forms of acute respiratory distress.
✕Less likely to help
Patients with stable chronic lung conditions who are not experiencing acute exacerbations may not receive direct benefits from this research.
What this research studies
This conference will focus on the interactions between epithelial and mesenchymal cells in the context of lung development and fibrosis, particularly in relation to the aftermath of severe lung injuries from conditions like COVID-19. Experts from various fields will gather to share the latest research findings and discuss strategies for improving lung repair and function. The aim is to bridge the gap between basic scientific discoveries and their application in clinical settings, ultimately enhancing patient care for those suffering from chronic respiratory diseases.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with chronic lung conditions.
How similar studies have gone: Previous conferences and research initiatives have successfully advanced understanding in related fields, indicating a strong potential for impactful outcomes from this gathering.
Where this research is happening
-
Mayo Clinic Rochester
Rochester, United States Active
Researchers
- Principal investigator: De Langhe, Stijn Piet Johan — Mayo Clinic Rochester
- Study coordinator: De Langhe, Stijn Piet Johan
Related research
Other NIH-funded projects on the same topics.
-
Interface between immune cells and scarring in the eye
This grant looks at how immune cells influence scar formation in the cornea after injury and how this affects vision.
-
How often to treat schistosomiasis to protect the liver
A randomized trial will test different frequencies ofPraziquantel treatment to prevent liver damage in people aged 15–40 with schistosomiasis in Uganda.
-
Metabolic changes in cells that repair blood vessels in the eye lens to prevent scarring
A drug or approach that changes how certain cells that repair blood vessels in the eye work, to prevent scarring behind the retina in age-related macular degeneration patients treated with anti-VEGF therapy.
-
Myocardial fibrosis and fat in ART-treated women with HIV in sub-Saharan Africa
This project studies heart tissue changes in women with HIV in sub-Saharan Africa who are on antiretroviral therapy, to understand why they’re at higher risk for heart problems as they age.
-
Myocardial fibrosis and fat in ART-treated women with HIV in sub-Saharan Africa
This grant studies heart tissue changes in women living with HIV in sub-Saharan Africa to understand why heart failure risk is higher in this group.
-
Molecular clues to progressive lung scarring
Researchers are studying how lung tissue becomes progressively scarred, focusing on cell signals and receptors that may drive fibrosis in people with lung disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.